Explore
Validate
Learn55374-1-AP
antibody from Proteintech Group
Targeting: TRIM33
FLJ11429, KIAA1113, PTC7, RFG7, TF1G, TIF1G, TIF1GAMMA, TIFGAMMA
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [7]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 55374-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#55374-1-AP, RRID:AB_11183035
- Product name
- TRIM33 antibody
- Antibody type
- Polyclonal
- Description
- TRIM33 antibody (Cat. #55374-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: WB,ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Lactate-induced miR-7-5p/TRIM33 reprograms metabolic flux to suppress tumor growth and viral reactivation.
Molecular recording of cellular protein kinase activity with chemical labeling.
DMC-BH derivative DMC-GF inhibits the growth of glioma stem cells by targeting the TRIM33/SLC25A1/mitochondrial oxidative phosphorylation pathway.
The deubiquitinase YOD1 suppresses tumor progression by stabilizing ZNF24 in clear cell renal carcinoma.
Nuclear translocation of PKM2 mediates keratinocyte metabolic reprogramming in psoriasis.
Downregulation of TRIM33 Promotes Survival and Epithelial-Mesenchymal Transition in Gastric Cancer.
Identification of proximal SUMO-dependent interactors using SUMO-ID.
Xu Y, Min X, Zhang Z, Zhang Y, Chen X, Wang X, Zhu C, Robertson E, Zhang Q, Tong Y, Zhang L, Wang Y, Cai Q
Molecular therapy : the journal of the American Society of Gene Therapy 2026 Feb 23;
Molecular therapy : the journal of the American Society of Gene Therapy 2026 Feb 23;
Molecular recording of cellular protein kinase activity with chemical labeling.
Sun DE, Ng SW, Zheng Y, Xie S, Schwan N, Breuer P, Hoffmann DC, Michel J, Azorin DD, Boonekamp KE, Winkler F, Wick W, Boutros M, Li Y, Johnsson K
Nature chemical biology 2025 Nov;21(11):1818-1827
Nature chemical biology 2025 Nov;21(11):1818-1827
DMC-BH derivative DMC-GF inhibits the growth of glioma stem cells by targeting the TRIM33/SLC25A1/mitochondrial oxidative phosphorylation pathway.
Shi L, Fei X, Huang J, He B, Sun Z, Sun G
Journal of translational medicine 2025 Mar 24;23(1):363
Journal of translational medicine 2025 Mar 24;23(1):363
The deubiquitinase YOD1 suppresses tumor progression by stabilizing ZNF24 in clear cell renal carcinoma.
Liu J, Lu Y, Zhu R, Xi P, Yang Z, Zhang Z, Xiong Y, Liu Y, Zhu Q, Sun T, Xie W, Gong B
Cell death & disease 2025 Apr 24;16(1):334
Cell death & disease 2025 Apr 24;16(1):334
Nuclear translocation of PKM2 mediates keratinocyte metabolic reprogramming in psoriasis.
Yang L, Zhang J, Hu C, Chen X, Yang Y, Tang H, Ding X, Yan Y
Experimental dermatology 2023 Nov;32(11):1960-1970
Experimental dermatology 2023 Nov;32(11):1960-1970
Downregulation of TRIM33 Promotes Survival and Epithelial-Mesenchymal Transition in Gastric Cancer.
Wang F, Wang W, Wu X, Tang C, Du F, Lu Z, Zhang Z, Xu H, Cao X, Li PA
Technology in cancer research & treatment 2022 Jan-Dec;21:15330338221114505
Technology in cancer research & treatment 2022 Jan-Dec;21:15330338221114505
Identification of proximal SUMO-dependent interactors using SUMO-ID.
Barroso-Gomila O, Trulsson F, Muratore V, Canosa I, Merino-Cacho L, Cortazar AR, Pérez C, Azkargorta M, Iloro I, Carracedo A, Aransay AM, Elortza F, Mayor U, Vertegaal ACO, Barrio R, Sutherland JD
Nature communications 2021 Nov 18;12(1):6671
Nature communications 2021 Nov 18;12(1):6671
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The TRIM33 antibody from Proteintech is a rabbit polyclonal antibody to a peptide of human TRIM33. This antibody recognizes human antigen. The TRIM33 antibody has been validated for the following applications: ELISA, WB analysis.
